Inhibrx Biosciences Inc. (NASDAQ:INBX) is one of the best emerging technology stocks to invest in. On December 16, Inhibrx ...

NYU Langone Health recently launched a molecular oncology program with clinical, research, and educational elements. NYU Langone Health has launched an innovative molecular oncology program. Molecular ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

Evaluating current models and diagnosing successful strategies for payers and physicians. Oncology disease is costly—in terms of drugs, hospitalizations, end-of-life care, imaging, and diagnostics.

According to Derek Raghavan, MD, director of the Taussig Cancer Institute in Cleveland, “a top cancer center needs to have a fusion of its clinical programs with its experimental and social support ...

Please provide your email address to receive an email when new articles are posted on . Novel therapeutics have led to significant survival improvements for many cancers. However, many of these ...

-- Update from Ongoing Phase 1 Clinical Trial of EO-3021 Now Expected Mid-2024 ---- Expanding EO-3021 Clinical Development Program to Include Combination Strategy -- -- Announcing HER3-targeting ADC ...

Please provide your email address to receive an email when new articles are posted on . The American Cancer Society launched a national training and credentialing program designed to standardize ...

Dr Benjamin George champions accessible cancer care in rural Nebraska, transforming patient support with innovative programs ...